NVAX
NASDAQ · Biotechnology
Novavax Inc
$7.32
-0.12 (-1.61%)
Open$7.44
Previous Close$7.44
Day High$7.49
Day Low$7.22
52W High$11.97
52W Low$6.20
Volume—
Avg Volume3.24M
Market Cap1.28B
P/E Ratio—
EPS$-0.61
SectorBiotechnology
Analyst Ratings
Buy
15 analysts
Price Target
+294.5% upside
Current
$7.32
$7.32
Target
$28.88
$28.88
$20.35
$28.88 avg
$29.25
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.14B | 1.37B | 441.16M |
| Net Income | 445.69M | 484.68M | -6,729,988 |
| Profit Margin | 39.2% | 37.2% | -1.5% |
| EBITDA | 457.22M | 524.84M | -8,036,743 |
| Free Cash Flow | — | — | -9,195,591 |
| Rev Growth | -17.2% | -17.2% | +6.7% |
| Debt/Equity | 0.75 | 0.75 | 0.98 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |